🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An Open-label, Phase II, Two-stage, Study of Xantrene® (Bisantrene) in comb...
Status
Unknown
Location
Chaim Sheba Medical Center
Start Date
2021-08-02
Trial ID
NCT04989335
Treatments Being Tested
This is a single arm,open-label, non-randomized phase 2 study to determine ...
Status
Unknown
Location
Shanghai Mengchao Cancer Hospital
Start Date
2021-06-04
Trial ID
NCT05472610
Treatments Being Tested
This clinical trial is a prospective, multicenter, open-label, randomized, ...
Status
Recruiting
Location
Mayo Clinic
Start Date
2025-01-14
Trial ID
NCT06743126
The purpose of this study is to assess the safety, tolerability, and clinic...
Status
Active Not Recruiting
Location
Hospital of the Universithy of Pennsylvania
Start Date
2024-08-05
Trial ID
NCT06152172
Treatments Being Tested
Patients with refractory and relapse lymphoblastic leukemia had poor outcom...
Status
Unknown
Location
Blood & Marrow Transplantation Center, RuiJin Hospital
Start Date
2016-01
Trial ID
NCT02766868
Treatments Being Tested
This example study evaluates the safety, tolerability, and preliminary anti...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07627711
The purpose of this study is to see the safety and efficient of neoantigen ...
Status
Unknown
Location
The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University
Start Date
2017-06-01
Trial ID
NCT03171220
Treatments Being Tested
This study is being done to determine how long it takes for the engraftment...
Status
Recruiting
Location
Wilmot Cancer Institute
Start Date
2015-06
Trial ID
NCT03016806
This is a phase I, open-label, single-arm study conducted in China to evalu...
Status
Unknown
Location
Hematology Hospital, Chinese Academy of Medical Sciences
Start Date
2022-04-28
Trial ID
NCT05727683
Treatments Being Tested
The study is a Phase II clinical trial. Patients will receive intensity-mod...
Status
Recruiting
Location
University of Illinois Cancer Center
Start Date
2025-02-04
Trial ID
NCT06802315